Order Total (1 Item Items):
Shipping Destination:
Screening Biological Response Modifiers (33 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (33)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (28)
- As New, Fine or Near Fine (3)
- Very Good or Good (1)
- Fair or Poor (1)
- As Described (No further results match this refinement)
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (16)
- Not Print on Demand (23)
Language (2)
Free Shipping
Seller Location
Seller Rating
-
-
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologySeller: PBShop.store UK, Fairford, GLOS, United Kingdom
Seller rating 4 out of 5 stars
US$ 106.98
US$ 5.59 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPAP. Condition: New. New Book. Shipped from UK. Established seller since 2000.
-
Screening for Biological Response Modifiers : Methods and Rationale
Book 21 of 78: Developments in OncologySeller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 106.96
US$ 20.15 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: New.
-
Condition: As New. Unread book in perfect condition.
-
Screening for Biological Response Modifiers: Methods and Rationale: 29 (Developments in Oncology)
Book 21 of 78: Developments in OncologyUS$ 113.98
US$ 20.81 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback. Condition: New.
-
Screening for Biological Response Modifiers: Methods and Rationale (Developments in Oncology)
Book 21 of 78: Developments in OncologySeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 120.40
US$ 16.09 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Screening for Biological Response Modifiers : Methods and Rationale
Book 21 of 78: Developments in OncologySeller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 126.97
US$ 20.15 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketCondition: As New. Unread book in perfect condition.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyLanguage: English
Published by Springer-Verlag New York Inc., US, 2011
ISBN 10: 1461296242 ISBN 13: 9781461296249
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: New. Softcover reprint of the original 1st ed. 1985.
-
Screening for Biological Response Modifiers: Methods and Rationale (Developments in Oncology, 29)
Book 21 of 78: Developments in OncologySeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 133.04
US$ 16.09 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyUS$ 131.16
US$ 20.81 shipping
Ships from United Kingdom to U.S.A.Quantity: 10 available
Add to basketPF. Condition: New.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyLanguage: English
Published by Springer-Verlag New York Inc., 2011
ISBN 10: 1461296242 ISBN 13: 9781461296249
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Seller rating 5 out of 5 stars
US$ 136.48
US$ 18.93 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback / softback. Condition: New. New copy - Usually dispatched within 3 working days.
-
Screening for Biological Response Modifiers
Book 21 of 78: Developments in OncologyLanguage: English
Published by Kluwer Academic Publishers, 1985
ISBN 10: 0898387124 ISBN 13: 9780898387124
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. Series: Developments in Oncology. Num Pages: 194 pages, black & white illustrations. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 12. Weight in Grams: 476. . 1985. Hardback. . . . .
-
Condition: New. pp. 212.
-
Kartoniert / Broschiert. Condition: New. The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search fo.
-
Taschenbuch. Condition: Neu. Screening for Biological Response Modifiers: Methods and Rationale | James E. Talmadge (u. a.) | Taschenbuch | xiv | Englisch | 2011 | Springer | EAN 9781461296249 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Screening for Biological Response Modifiers
Book 21 of 78: Developments in OncologyLanguage: English
Published by Kluwer Academic Publishers, 1985
ISBN 10: 0898387124 ISBN 13: 9780898387124
Condition: New. Series: Developments in Oncology. Num Pages: 194 pages, black & white illustrations. BIC Classification: MJCL. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 12. Weight in Grams: 476. . 1985. Hardback. . . . . Books ship from the US and Ireland.
-
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for 'screening' drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyLanguage: English
Published by Springer US, Springer US, 1985
ISBN 10: 0898387124 ISBN 13: 9780898387124
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for 'screening' drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyLanguage: English
Published by Springer-Verlag New York Inc., US, 2011
ISBN 10: 1461296242 ISBN 13: 9781461296249
US$ 140.78
US$ 87.32 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback. Condition: New. Softcover reprint of the original 1st ed. 1985.
-
Screening for Biological Response Modifiers: Methods and Rationale (Developments in Oncology, 29)
Book 21 of 78: Developments in OncologyUS$ 214.48
US$ 33.59 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback. Condition: Like New. Like New. book.
-
Screening for Biological Response Modifiers: Methods and Rationale (Developments in Oncology, 29)
Book 21 of 78: Developments in OncologyUS$ 214.48
US$ 33.59 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketHardcover. Condition: Very Good. Very Good. book.
-
Screening for Biological Response Modifiers: Methods and Rationale (Developments in Oncology, 29)
Published by Springer, 1985
hardcover. Condition: Acceptable. Ex- Library no dust jacket medium wear to book edges and cover . Library stickers and stamps are present . Some corner dings.
-
Condition: new. Questo è un articolo print on demand.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyUS$ 140.90
US$ 13.43 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback. Condition: Brand New. 9.20x6.10 inches. In Stock. This item is printed on demand.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyLanguage: English
Published by Springer US Apr 1985, 1985
ISBN 10: 0898387124 ISBN 13: 9780898387124
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for 'screening' drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6). 212 pp. Englisch.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyUS$ 110.49
US$ 56.95 shipping
Ships from Germany to U.S.A.Quantity: Over 20 available
Add to basketGebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search fo.
-
Screening for Biological Response Modifiers: Methods and Rationale
Book 21 of 78: Developments in OncologyLanguage: English
Published by Springer US Nov 2011, 2011
ISBN 10: 1461296242 ISBN 13: 9781461296249
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for 'screening' drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6). 212 pp. Englisch.
-
US$ 183.72
US$ 8.73 shipping
Ships from United Kingdom to U.S.A.Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 212 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.
-
Buch. Condition: Neu. Screening for Biological Response Modifiers: Methods and Rationale | James E. Talmadge (u. a.) | Buch | xiv | Englisch | 1985 | Springer US | EAN 9780898387124 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
